Oscar Health Drops 8.1% as Co-Founder Mario Schlosser Leaves CTO Role
Updated
Updated · Quiver Quantitative · Jun 2
Oscar Health Drops 8.1% as Co-Founder Mario Schlosser Leaves CTO Role
1 articles · Updated · Quiver Quantitative · Jun 2
Summary
Oscar Health shares fell 8.1% after an SEC-filed update showed co-founder Mario Schlosser moving from President of Technology and CTO to a co-founder and advisor role.
The filing described the move as a planned transition, but the sharp intraday decline and heavy trading suggested investors saw it as a risk to product execution and platform continuity.
Insider activity adds to that scrutiny: over the past six months, Oscar insiders made 19 open-market trades, with 18 sales and just one purchase; Schlosser accounted for seven sales totaling 421,996 shares.
Institutional positioning has also been mixed, with 212 investors cutting holdings in their latest quarter versus 177 adding, even as recent analyst price targets carried a $19 median and Barclays set a $30 target on May 26.